Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GammaKnife vs Standard Radiation for Newly Diagnosed GBM
NCT02085304Phase 2Terminated
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- May 2013
- Primary completion
- May 2015
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by St. Joseph's Hospital and Medical Center. Primary endpoints: Change in health related quality of life at 24 months and Time without Cognitive impairment at 24 months. Started May 2013; status: terminated.
Beyond the preview
Go deeper on NCT02085304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085304.